Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey (Q37955638)

25 August 2017

title

Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey (English)

1 reference

chronic granulomatous disease

25 August 2017

main subject

1 reference

9

Alain Fischer

0 references

Marianne Debré

5

object named as

Marianne Debré

0 references

Nizar Mahlaoui

object named as

Nizar Mahlaoui

3

0 references

Olivier Lortholary

7

object named as

Olivier Lortholary

1 reference

25 August 2017

8

Stéphane Blanche

1 reference

25 August 2017

2

Richard Mouy

1 reference

25 August 2017

Sophie Blumental

1

1 reference

25 August 2017

Marie-Elisabeth Bougnoux

4

1 reference

25 August 2017

Julien Beauté

6

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 December 2011

1 reference

Clinical Infectious Diseases

25 August 2017

published in

1 reference

25 August 2017

volume

53

1 reference

25 August 2017

issue

12

1 reference

25 August 2017

page(s)

e159-69

1 reference

Genetic, biochemical, and clinical features of chronic granulomatous disease.

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Chronic granulomatous disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Chronic granulomatous disease: the European experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Long-term follow-up and outcome of 39 patients with chronic granulomatous disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Residual NADPH oxidase and survival in chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Chronic familial granulomatosis. Report of five cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Chronic granulomatous disease. Report on a national registry of 368 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Clinical features and prognoses of 23 patients with chronic granulomatous disease followed for 21 years by a single hospital in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Follow up of patients with chronic granulomatous disease diagnosed since 1990

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Modern management of chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Osteomyelitis due to Aspergillus spp. in patients with chronic granulomatous disease: comparison of Aspergillus nidulans and Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Itraconazole to prevent fungal infections in chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

New therapies for fungal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

The French national registry of primary immunodeficiency diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Epidemiology and outcome of invasive fungal diseases in patients with chronic granulomatous disease: a multicenter study in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Preventing fungal infections in chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47phox-/- mouse model of chronic granulomatous disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Aspergillus nidulans is frequently resistant to amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Emericella quadrilineata as cause of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Hematopoietic stem cell transplantation for chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Aspergillus nidulans Infection in Chronic Granulomatous Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

Fungal infection in chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR731

21 January 2018

Identifiers

DOI

10.1093/CID/CIR731

1 reference

25 August 2017

1 reference